SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-017259
Filing Date
2019-05-08
Accepted
2019-05-08 16:35:10
Documents
72
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cnst-10q_20190331.htm 10-Q 2107238
2 EX-31.1 cnst-ex311_9.htm EX-31.1 9607
3 EX-31.2 cnst-ex312_8.htm EX-31.2 9580
4 EX-32.1 cnst-ex321_6.htm EX-32.1 5675
5 EX-32.2 cnst-ex322_7.htm EX-32.2 5755
  Complete submission text file 0001564590-19-017259.txt   6448268

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cnst-20190331.xml EX-101.INS 1287548
7 XBRL TAXONOMY EXTENSION SCHEMA cnst-20190331.xsd EX-101.SCH 47978
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cnst-20190331_cal.xml EX-101.CAL 48088
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cnst-20190331_def.xml EX-101.DEF 125839
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cnst-20190331_lab.xml EX-101.LAB 355334
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cnst-20190331_pre.xml EX-101.PRE 269943
Mailing Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 200 CAMBRIDGE MA 02142 617-714-0555
CONSTELLATION PHARMACEUTICALS INC (Filer) CIK: 0001434418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38584 | Film No.: 19807176
SIC: 2834 Pharmaceutical Preparations